[11C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology

Neurology

Volumn 54, Issue 12, 2000, Pages 2252-2260

  Lamusuo, S ^b   Pitkanen A ^b   Jutila, L ^b   Ylinen, A ^b   Partanen, K ^b   Kalviainen R ^b   Ruottinen, H M ^b   Oikonen, V ^b   Nagren K ^b   Lehikoinen, P ^b   Vapalahti, M ^b   Vainio, P ^b   Rinne, Juha O ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE

Author keywords

Epilepsy; Flumazenil; MR volumetry; Neuropathology; T2 relaxometry

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBON 11; CLONAZEPAM; FLUMAZENIL; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID; VIGABATRIN; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; DIAGNOSTIC AGENT;

ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; DRUG BINDING; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; MALE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY; VOLUMETRY; ADOLESCENT; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; TEMPORAL LOBE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; BENZODIAZEPINES; EPILEPSY, TEMPORAL LOBE; FEMALE; FLUMAZENIL; GABA MODULATORS; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME; VALPROIC ACID; VIGABATRIN;

EID: 0034720687     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.12.2252     Document Type: Article

References (42)

1. Babb TL, Brown WJ, Pretorius J, Davenport C, Lieb JP, Crandall PH. Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia 1984;25:729-740.
2. Sutula T, Cascino G, Cavazos J, Parada I, Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989;26:321-330.
3. Babb TL, Pretorius JK. Pathologic substrates of epilepsy. In: Wylie E, ed. The treatment of epilepsy: principles and practice. Philadelphia: Lea & Fibiger, 1993:55-70.
4. Sloviter RS. The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann Neurol 1994;35:640-654.
5. Johnson EW, de Lanerolle NC, Kim JH, et al. "Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology 1992;42:811-815.
6. Burdette DE, Sakurai SY, Henry TR, et al. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology 1995;45:934-941.
7. Hand KSP, Baird VH, Van Paesschen W, et al. Central benzodiazepine receptor autoradiography in hippocampal sclerosis. Br J Pharmacol 1997;122:358-364.
8. Bronen RA, Fulbright RK, King D, et al. Qualitative MR imaging of refractory temporal lobe epilepsy requiring surgery: correlation with pathology and seizure outcome after surgery. AJR Am J Roentgenol 1997;169:875-882.
9. Van Paesschen W, Connelly A, Ling MD, Jackson GD, Duncan JS. The spectrum of hippocampal sclerosis: a quantitative magnetic resonance imaging study. Ann Neurol 1997;41:41-51.
10. 18F]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 1993;56:615-621.
11. Henry TR, Frey KA, Sackellares JC, et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 1993;43:1998-2006.
12. Koepp MJ, Richardson MP, Brooks DJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis: an objective in vivo analysis. Brain 1996;119:1677-1687.
13. Szelies B, Weber-Luxenburger G, Pawlik G, et al. MRI-guided flumazenil-and FDG-PET in temporal lobe epilepsy. Neuro-Image 1996;3:109-118.
14. 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J Neurol Neurosurg Psychiatry 1997;62:141-150.
15. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy. Neurology 1997;49:764-773.
16. 3H]flumazenil autoradiography in hippocampal sclerosis. Ann Neurol 1998;43:618-626.
17. 123I]-iomazenil-SPECT in localizing the epileptogenic cortex. J Neurol Neurosurg Psychiatry 1997;63:743-748.
18. 11C-labelling of its metabolite Ro 15-3890, for PET studies of benzodiazepine receptors. Appl Radiat Isot 1988;39:993-997.
19. Aquilonius SM, Eckernäs S. A color atlas of the human brain. New York: Raven Press, 1980.
20. Lammertsma A, Hume S. Simplified reference tissue model for PET receptor studies. NeuroImage 1996;4:153-158.
21. Logan J, Fowler JS, Volkow ND, Wang G-J, Ding Y-S, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16:834-840.
22. 11C]flumazenil. J Cereb Blood Flow Metab 1991;11:745-752.
23. Soininen H, Partanen K, Pitkänen A, et al. Volumes of the amygdala and the hippocampus in age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994;44:1660-1668.
24. Kälviäinen R, Salmenperä T, Partanen K, Vainio P, Riekkinen P Sr, Pitkänen A. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology 1998; 50:1377-1382.
25. Jackson GD, Connelly A, Duncan JS, Grunewald RA, Gadian DG. Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 1993;43:1793-1799.
26. Pitkänen A, Laakso M, Kälviäinen R, et al. Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease. Neurology 1996;46:1724-1730.
27. Sorvari H, Soininen H, Paljärvi L, Karkola K, Pitkänen A. Distribution of parvalbumin immunoreactive cells and fibers in human amygdaloid complex. J Comp Neurol 1995;360:185-212.
28. Mikkonen M, Soininen H, Kälviäinen R, et al. Remodelling of neuronal circuitries in human temporal lobe epilepsy: increased expression of highly polysialyted NCAM in the hippocampus and the entorhinal cortex. Ann Neurol 1998;44: 923-934.
29. Watson C, Nielsen SL, Cobb C, Burgerman R, Williamson B. Pathological grading system for hippocampal sclerosis: correlation with magnetic resonance imaging-based volume measurements of the hippocampus. J Epilepsy 1996;9:56-64.
30. Houser CR, Miyashiro JE, Swartz BE, Walsh GO, Rich JR, Delgado-Escueta AV. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J Neurosci 1990;10:267-282.
31. Cavazos JE, Golarai G, Sutula TP. Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence. J Neurosci 1991;11:2795-2803.
32. Engel J Jr. Outcome with respect to seizures. In: Engel J Jr, ed. Surgical treatment of the epilepsies. New York: Raven Press, 1987:553-572.
33. Pitkänen A, Tuunanen J, Kälviäinen R, Partanen K, Salmenperä T. Amygdala damage in experimental and human temporal lobe epilepsy. Epilepsy Res 1998;32:233-253.
34. Du F, Whetsell WO, Abou-Khalil B, Blumenkopf B. Preferential neuronal loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy. Epilepsy Res 1993;16:223-233.
35. Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 1998;4:1166-1172.
36. 11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997; 120:1865-1876.
37. 11C]flumazenil binding after epilepsy surgery. Acta Neurol Scand 1998;97:279-286.
38. 18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. Brain 1998;212:2067-2081.
39. Brouillet E, Chavoix C, Bottlaender M, et al. In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates. Brain Res 1991;557:167-176.
40. Frey KA, Holthoff VA, Koeppe RA, et al. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol 1991;30:663-672.
41. Savic I, Svanborg E, Thorell JO. Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study. Epilepsia 1996;37:236-244.
42. Jack CR, Trenerry MR, Cascino GD, Sharbrough FW, So EL, O'Brien PC. Bilaterally symmetric hippocampi and surgical outcome. Neurology 1995;45:1352-1358.